A separate study found that anti‐PD‐L1 therapy alone failed to control orthotopic CCA in mice58; however, depleting both PMN‐MDSCs and TAMs enhanced the therapeutic response, suggesting that targeting PMN‐MDSCs may improve ICI efficacy in CCA.58 This evidence concerns the gene CD274 and cholangiocarcinoma.